Feature | August 06, 2014

Medtronic, Acist Enter Agreement to Commercialize Next Generation FFR-IVUS Technologies

Collaboration provides increased commercial reach, brand synergies and customer access to new technologies

Medtronic, Acist Agreement FFR-IVUS Technologies

August 6, 2014  — Acist Medical Systems announced it entered into a strategic agreement with Medtronic to co-promote the world’s first Rapid Exchange FFR (RXi) and high definition IVUS (HDi) technologies in the United States. Under this agreement, Acist and Medtronic will work collaboratively to introduce these groundbreaking products into cardiac catheterization laboratories across the United States.

Fractional flow reserve (FFR) has quickly become the standard that interventional cardiologists use to determine which patients can most benefit from stenting. Intravascular ultrasound (IVUS) is an advanced diagnostic modality that provides greater insight into arterial disease than standard angiography alone. The Acist RXi and HDi systems are quicker, easier to use and offer detailed insight that physicians can use to optimize treatment choice for their patients.

Through this collaboration, Acist and Medtronic will bring this technology to existing and new customers who value improved modalities that simplify procedures and benefit their patients.

Acist’s new Rapid FFR system, which utilizes the ultra-thin Acist Navvus Rapid Exchange MicroCatheter and RXi console, was introduced earlier this year in the United States and Europe. The Navvus MicroCatheter can be used over a standard 0.014-inch guidewire, and the RXi system facilitates rapid FFR assessments before, during and post-intervention. This technology is the first of its kind, providing the reassurance of accurate and reliable FFR measurements and the advantages of Rapid Exchange technology.

This agreement makes Acist/Medtronic the forth vendor for FFR and IVUS systems in the U.S. market.

For more information: www.acist.com, www.bracco.com, www.medtronic.com

Related Content

Videos | TCT| November 15, 2017
DAIC Editor Dave Fornell shows some of the innovations displayed on the expo floor at the 2017 Transcatheter Cardiova
Videos | FFR Technologies| November 15, 2017
A discussion with William Fearon, M.D.
GE Healthcare and Medis Collaborate to Expand Availability of Quantitative Flow Ratio Software
News | FFR Technologies| November 10, 2017
GE Healthcare and Dutch-based cardiovascular imaging software provider Medis announced at the 2017 Transcatheter...
FAVOR II Studies Examine Diagnostic Accuracy of Quantitative Flow Ratio, FFR-Angio.
News | FFR Technologies| November 08, 2017
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017...
FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone. TCT 2017

FAME2 cost effectiveness of FFR guided PCI vs. medical therapy alone.

News | FFR Technologies| November 06, 2017
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a p
HeartFlow's FFR-CT (FFRct) analysis software can create a virtual FFR to assess coronary artery disease.

HeartFlow's FFR-CT analysis software uses a computed tomography scan and supercomputing fluid dynamics software to create a noninvasive, virtual FFR map of the entire coronary artery tree to determine the flow-limiting severity of ant lesions. 

News | Cardiac Imaging| November 06, 2017
November 6, 2017 – The Centers for Medicare & Medicaid Services (CMS) has finalized a New Technology Ambulatory P
Acist Medical Systems Announces Approval and Launch of Next-Generation FFR System
Technology | FFR Technologies| November 03, 2017
Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini System, the next-...
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Overlay Init